Your browser doesn't support javascript.
loading
HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.
Jin, Kideok; Park, Sunju; Teo, Wei Wen; Korangath, Preethi; Cho, Sean Soonweng; Yoshida, Takahiro; Gyorffy, Balázs; Goswami, Chirayu Pankaj; Nakshatri, Harikrishna; Cruz, Leigh-Ann; Zhou, Weiqiang; Ji, Hongkai; Su, Ying; Ekram, Muhammad; Wu, Zhengsheng; Zhu, Tao; Polyak, Kornelia; Sukumar, Saraswati.
Afiliación
  • Jin K; Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Park S; Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Teo WW; Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Korangath P; Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Cho SS; Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Yoshida T; Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Gyorffy B; MTA TTK Lendület Cancer Biomarker Research Group and 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Goswami CP; Center for Computational Biology and Bioinformatics, Indiana University, Bloomington, Indiana.
  • Nakshatri H; Center for Computational Biology and Bioinformatics, Indiana University, Bloomington, Indiana.
  • Cruz LA; Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Zhou W; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Ji H; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Su Y; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Ekram M; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wu Z; Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
  • Zhu T; Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
  • Polyak K; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sukumar S; Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. saras@jhmi.edu.
Cancer Discov ; 5(9): 944-59, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26180042
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Receptor ErbB-2 / Proteínas de Homeodominio / Resistencia a Antineoplásicos / Antineoplásicos Hormonales / Receptor alfa de Estrógeno Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Discov Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Receptor ErbB-2 / Proteínas de Homeodominio / Resistencia a Antineoplásicos / Antineoplásicos Hormonales / Receptor alfa de Estrógeno Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Discov Año: 2015 Tipo del documento: Article